Home › Funds › Jones Hill Capital LP › VRTX

Jones Hill Capital LP position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Jones Hill Capital LP reported holding 11,123 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$5.5M, representing 1.17% of its reported portfolio and ranking #25 among its reported holdings. Jones Hill Capital LP has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)11.12K sh
Reported value held$5.53M
Portfolio Weight1.17%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Jones Hill Capital LP's VRTX position evolved

Jones Hill Capital LP first disclosed a stake in VRTX in Q1 2026 at 108,603 shares (US$48.5M). Across 2 filings, Jones Hill Capital LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 11,123 shares valued at US$5.5M — a reduction of -97,480 shares quarter over quarter.. Notable position changes include a 90% trim in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 108.60K $48.50M New
Q2 2026 11.12K $5.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Jones Hill Capital LP held VRTX?

Jones Hill Capital LP has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Jones Hill Capital LP's current position in VRTX?

As of Q2 2026, Jones Hill Capital LP holds 11.12K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $5.53M, representing 1.17% of its reported portfolio and ranking #25.

Has Jones Hill Capital LP been buying or selling VRTX?

In the latest 13F filing (Q2 2026), Jones Hill Capital LP reduced its position in VRTX.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.